Efficacy of cytotoxic chemotherapy in recurrent/metastatic adenoid cystic carcinoma (ACC)

被引：0
|
作者：
Wotman, Michael
Hoff, Camilla Oliveira
Bonini, Flavia
Sawyer, Matthew
Wang, Kaiwen
Dal Lago, Eduardo Andreazza
de Sousa, Luana Guimaraes
Ferrarotto, Renata
机构：
[1] MD Anderson Hematol Oncol Fellowship, Houston, TX USA
[2] Univ Sao Paulo, Sao Paulo, Brazil
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Div Pharm, Houston, TX USA
[5] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6111
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of dovitinib in patients with recurrent or metastatic adenoid cystic carcinoma (ACC).
    Dillon, Patrick Michael
    Petroni, Gina R.
    Moskaluk, Chris
    Fracasso, Paula M.
    Douvas, Michael G.
    Perez, Jose Ricardo
    Varhegyi, Nikole
    Zaja-Milatovic, Snjezana
    Thomas, Christopher Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Lenvatinib for Recurrent Metastatic Adenoid Cystic Carcinomas (ACC) of the Lung
    Al Rabadi, L.
    Tolba, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1041 - S1041
  • [3] Treatment of Recurrent or Metastatic Adenoid Cystic Carcinoma
    Luana Guimaraes de Sousa
    Felippe Lazar Neto
    Jessica Lin
    Renata Ferrarotto
    Current Oncology Reports, 2022, 24 : 621 - 631
  • [4] Treatment of Recurrent or Metastatic Adenoid Cystic Carcinoma
    de Sousa, Luana Guimaraes
    Neto, Felippe Lazar
    Lin, Jessica
    Ferrarotto, Renata
    CURRENT ONCOLOGY REPORTS, 2022, 24 (05) : 621 - 631
  • [5] A phase 2 clinical trial of axitinib and avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (ACC).
    Ferrarotto, Renata
    Bell, Diana
    Feng, Lei
    Li, Kaiyi
    Mott, Frank
    Blumenschein, George R.
    De Sousa, Luana Guimaraes
    Altan, Mehmet
    Marques-Piubelli, Mario L.
    Dal Lago, Eduardo Andreazza
    Kaya, Diana
    Godoy, Myrna
    Kupferman, Michael Elliot
    Glisson, Bonnie S.
    El-Naggar, Adel K.
    Elamin, Yasir Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma
    Ho, Allen S.
    Ochoa, Angelica
    Jayakumaran, Gowtham
    Zehir, Ahmet
    Mayor, Cristina Valero
    Tepe, Justin
    Makarov, Vladimir
    Dalin, Martin G.
    He, Jie
    Bailey, Mark
    Montesion, Meagan
    Ross, Jeffrey S.
    Miller, Vincent A.
    Chan, Lindsay
    Ganly, Ian
    Dogan, Snjezana
    Katabi, Nora
    Tsipouras, Petros
    Ha, Patrick
    Agrawa, Nishant
    Solit, David B.
    Futreal, P. Andrew
    El Naggar, Adel K.
    Reis-Filho, Jorge S.
    Weigelt, Britta
    Ho, Alan L.
    Schultz, Nikolaus
    Chan, Timothy A.
    Morris, Luc G. T.
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (10): : 4276 - 4289
  • [7] Adenoid cystic carcinoma (ACC) of the larynx (LACC)
    Wilson, RW
    Wenig, BM
    LABORATORY INVESTIGATION, 1997, 76 (01) : 686 - 686
  • [8] Predictive biomarkers of benefit to axitinib plus avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (R/M ACC)
    Hoff, Camilla Oliveira
    McGrail, Daniel
    Heeke, Simon
    de Sousa, Luana Guimaraes
    Li, Kaiyi
    Bell, Diana
    Mitani, Yoshitsugu
    Marques-Piubelli, Mario L.
    Cortez, Maria Angelica
    Lin, Shiaw-Yih
    Elamin, Yasir Y.
    El-Naggar, Adel K.
    Ferrarotto, Renata
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Efficacy of NOTCH inhibitors (Ni) relative to prior systemic therapy or observation in patients (pts) with recurrent/ metastatic (R/M) adenoid cystic carcinoma (ACC)
    Hoff, C. O.
    de Sousa, L. G.
    Bonini, F.
    Dal Lago, E.
    Wang, K.
    Siqueira, J. Mota
    Cortez, M. A.
    Mitani, Y.
    Purushothaman, A.
    El-Naggar, A.
    Ferrarotto, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S577 - S578
  • [10] Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma
    Desilets, Antoine
    Vos, Joris L.
    Katabi, Nora
    Kuo, Fengshen
    Nadeem, Zaineb
    Linxweiler, Maximilian
    Ostrovnaya, Irina
    Baxi, Shrujal
    Dunn, Lara A.
    Sherman, Eric J.
    Pfister, David G.
    Morris, Luc G. T.
    Ho, Alan L.
    CLINICAL CANCER RESEARCH, 2024, 30 (23) : 5281 - 5292
12345